2017
DOI: 10.1155/2017/2948467
|View full text |Cite
|
Sign up to set email alerts
|

HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression

Abstract: Background. Breast cancer remains the leading cause of cancer-related mortality worldwide. It has been indicated that human papillomaviruses 16 (HPV16) might participate in the pathogenesis and development of breast cancer. However, the detected rate of HPV16 varies with region. We will investigate HPV16 E6 expression in North China and explore the effects and mechanism of HPV16 E6 on breast cancer proliferation in this study. Methods. The expressions of HPV16 E6 and COX-2 in paraffin-embedded tissues of the i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 42 publications
(31 reference statements)
0
6
0
Order By: Relevance
“…Cyclo-oxygenase-2 (COX-2) is a key enzyme in eicosanoid biosynthesis. In previous studies, upregulated COX-2 expression has been observed in a number of malignant tumors, such as breast cancer and colon cancers 4,5 . The overexpression of COX-2 is related to prostaglandin-stimulating angiogenesis and proliferation, which can promote cell invasion and the development of metastases 6 .…”
Section: Introductionmentioning
confidence: 88%
“…Cyclo-oxygenase-2 (COX-2) is a key enzyme in eicosanoid biosynthesis. In previous studies, upregulated COX-2 expression has been observed in a number of malignant tumors, such as breast cancer and colon cancers 4,5 . The overexpression of COX-2 is related to prostaglandin-stimulating angiogenesis and proliferation, which can promote cell invasion and the development of metastases 6 .…”
Section: Introductionmentioning
confidence: 88%
“…Under inflammatory conditions, iNOS and COX‐2 protein expression are elevated, which facilitates the generation of NO and Prostaglandin F2 alpha (PGF 2α ). iNOS is a target of inflammation‐associated tissue damage (Southan & Szabo, ), and COX‐2 is a mediator of inflammation, angiogenesis, and cancer progression (Wang et al, ). Also, cytokines that include TNF‐α and IL‐6 are related to the inflammation process and known to typical proinflammatory cytokine with tumor growth effect (Landskron, De la Fuente, Thuwajit, Thuwajit, & Hermoso, ).…”
Section: Discussionmentioning
confidence: 99%
“…We could not identify any previous epidemiologic studies that have assessed the impact of nonaspirin NSAID use and risk of HNC in relation to HPV, and preclinical evidence concerning the association between HPV and COX‐2 expression is limited and inconsistent. Studies on cervical cancer cell lines and tissue have found upregulation of COX‐2 expression in HPV‐positive compared to HPV‐negative tumor cells, while others reported no correlation . In HNC, one study found increased expression of COX‐2 in an HPV‐transformed dysplastic cell line, while two small studies found no or an inverse association between COX‐2 expression and HPV positivity in human HNC samples …”
Section: Discussionmentioning
confidence: 99%